E-drug: Prescrire International, April 1998 Issue
----------------------------------------------------
Table of contents
Prescrire International, April 1998, Volume 7, Nr 34
Prescrire International is the English language edition of La revue
Prescrire. It consists of a selection of articles of international interest
from the monthly French-language journal La revue Prescrire.
Prescrire International contains evaluations of new drugs and new
indications, information on adverse effects, and assessments of
therapeutic interventions.
EDITORIAL
Current trends
NEW PRODUCTS
Ropinirole (new preparation)
Comparative assessment of this antiparkinsonian must continue
Alendronic acid (new preparation)
Limited efficacy for post-menopausal women with osteroporotic fracture
Liposomal daunorubicin (new preparation)
Occasional complete remission of Kaposi's lesions
Vigabatrin (new indication)
Of use for infantile spasms
Ifosfamide (new indications-new dose strength)
Possibly helpful in a number of carcinomas
Topotecan (new preparation)
No firm conclusion on utility for metastatic ovarian carcinoma
Benfluorex: what use? (a second look)
No proven benefit in hypertriglyceridaemic patients
Milnacipran (new preparation)
No advantage over existing antidepressants
ADVERSE EFFECTS
Gingival hyperplasia due to calcium antagonists
Nifedipine most commonly involved
Drug-induced benign intracranial hypertension
Prompt withdrawal is crucial to avoid visual involvement
REVIEWS
Terminal care
Nonpain symptom management
The index 1993-1997 is published as a supplement to the April issue of
Prescrire International.
Prescrire International is financed by subscription fees only. We
cannot provide free subscriptions. If you do not know the journal we
can send you a sample issue. Send us your name and address if you
want to receive a sample issue of Prescrire International. An annual
subscription covers six issues of Prescrire International plus an index
to issues during the previous five years and costs $ 60 (FF 310) for
individuals, $38 (FF 200) for students, and 360$ (FF1860) for
commercial institutions.
Prescrire International
Association Mieux Prescrire
BP 459
75527 Paris Cedex 11
France
Tel. 33 1 47 00 94 45
Fax 33 1 48 07 87 32
email : international@prescrire.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.